SCHEMBL29688741

SCHEMBL29688741

CCOc1c(C(C)=O)cc(Cl)c(C)c1N1CCOCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.47
ALDH1A1 P00352 5/20 0.41
DYRK1A Q13627 1/20 0.41
MAPT P10636 5/20 0.40
POLB P06746 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PIK3CA P42336 1/20 0.40
PRKDC P78527 1/20 0.40
HCAR1 Q9BXC0 2/20 0.39
HCAR2 Q8TDS4 1/20 0.39
NPC1 O15118 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20254958 1.00 PKM (0.47) PKMALDH1A1DYRK1AMAPTPOLB
SCHEMBL20254816 0.81 PKM (0.42) PKMALDH1A1DYRK1AMAPTPOLB
SCHEMBL29688382 0.81 PKM (0.42) PKMALDH1A1DYRK1AMAPTPOLB
SCHEMBL29688354 0.80 PKM (0.41) PKMALDH1A1DYRK1AMAPTTSHR
SCHEMBL20254625 0.80 PKM (0.41) PKMALDH1A1DYRK1AMAPTTSHR
SCHEMBL20254710 0.78 SMN1; SMN2 (0.41) PKMALDH1A1DYRK1AMAPTPOLB
SCHEMBL29688572 0.78 SMN1; SMN2 (0.41) PKMALDH1A1DYRK1AMAPTPOLB
SCHEMBL14753937 0.76 TSHR (0.46) ALDH1A1MAPTPOLBTSHRHTT
SCHEMBL29688577 0.74 ALDH1A1 (0.39) PKMALDH1A1DYRK1APOLBTSHR
SCHEMBL20255000 0.74 ALDH1A1 (0.39) PKMALDH1A1DYRK1APOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110267959-B Imidazo [1,5-A ] pyrazine derivatives as PI3K delta inhibitors 百济神州有限公司 2022-05-27 CN disclosed